|
Don't Count Your Chips Just Yet In a 64-33 vote today, the Senate voted to
approve the Chips and Science Bill, a
measure that authorizes roughly $280 billion for U.S. manufacturing,
including $52 billion in subsidies and grants for the U.S. semiconductor
industry. The measure now goes to the House of Representatives for a final
vote, then heads to President Joe Biden’s desk for his signature. That could
happen by the end of the week. Semiconductor stocks rallied on the news:
the iShares Semiconductor exchange-traded fund (SOXX) rose 4.6%, Intel
added 3.1%, Nvidia jumped 7.6%, and Advanced
Micro Devices gained 5.4%. The bill includes financial incentives for
companies to open new manufacturing plants inside the U.S. But Barron's
chips expert Tae Kim thinks the measure is
at best an "incremental positive" for the industry. He wrote
today: While the $50-billion-plus
number looks large on the surface, the magnitude shouldn’t be overstated as
it will be spread out over five years, making the overall impact more
limited. According to IC Insights, total
semiconductor industry capital spending is estimated to grow 24% this year,
to $190 billion. Assuming some growth over the next several years, the bill
would be a modest single digit percentage of the aggregate spending over the
five-year time period. The bill is “frankly, a
rounding error given the scale of investments required in this space,” Bernstein
analyst Stacy Rasgon
wrote in a note last week. “While we do believe passage could be a modest
positive for our sector and some stocks at least on sentiment, we do not
believe it would have a hugely meaningful impact.” More high-paying manufacturing jobs and
the national security benefits of domestic chipmaking are merits of the bill,
but they won't change the chip industry's biggest problem these days. That
has to do with economic fundamentals. Tae continues: The problem is the chip industry may now be
facing challenges on the demand side—not the supply side. Demand for two of
the industry’s key markets—computers and mobile phones—seems to be
deteriorating rapidly amid the slowing global economy. ...Unfortunately for semiconductor
companies, this may be the beginning of longer downturn without any
turnaround for the intermediate future. Many consumers pulled forward their
spending on computer electronics, laptops, smartphones, and other technology
products when they were stuck at home during the pandemic. Most of these
items don’t need to be upgraded or replaced for years, which could make for
sluggish sales for the chip industry for some time to come. Until customers are convincingly growing
their spending on semiconductors, the outlook for chip stocks isn't as rosy
as today's bounce would make it seem. Read the rest of Tae's report here. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Friday, August 26, 2022
Don't Count Your Chips Just Yet
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment